EI
AURA icon

Ethic Inc’s Aura Biosciences AURA Stock Holding History

Ethic Inc’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,539
Closed -$95.6K – 1238
2025
Q4 		$95.6K Buy
17,539
+2,598
+17% +$15.4K ﹤0.01% 1180
2025
Q3 		$92.3K Buy
+14,941
New +$97.7K ﹤0.01% 1153

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ethic Inc's AURA Position: Q1 2026 in Review

Ethic Inc sold out of Aura Biosciences (AURA) in Q1 2026, closing a stake of 17,539 shares — an estimated $95.6K sold.

Ethic Inc first reported a position in AURA in Q3 2025 and held it in 2 quarters. The position peaked at $95.6K in Q4 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Ethic Inc reported no remaining Aura Biosciences position as of Q1 2026 after selling out during the quarter.
  • Ethic Inc sold 17,539 Aura Biosciences shares in Q1 2026, an estimated $95.6K.
  • Ethic Inc first reported a position in Aura Biosciences in Q3 2025 and held it in 2 quarters.
  • Ethic Inc's Aura Biosciences position peaked at $95.6K in Q4 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.